Hims & Hers compounder received FDA warning letter| STAT
The Food and Drug Administration late last year issued a warning letter to MedisourceRx, a compounding pharmacy owned…
What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
Hims An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,…
FDA’s Lethargy Is Harming Women
American women are silently suffering while the Food and Drug Administration drags its feet on reviewing the abortion…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
Over-the-counter ivermectin sales proposed in Georgia
ATLANTA, Ga. (Atlanta News First) — A Georgia state lawmaker wants to allow over-the-counter sales of a drug…
Expert guide to all the types of GLP-1 drugs available in 2026
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word…
How to find trusted, high-quality vitamins without overpaying
Thinking about taking supplements to jump-start your health goals? Because supplements aren’t tightly regulated before hitting the market,…
Will 2026 FDA Decisions on Afrezza and FUROSCIX Redefine MannKind’s (MNKD) Narrative
Earlier in January, MannKind Corporation outlined upcoming 2026 regulatory milestones, including FDA decisions on Afrezza label updates, a…
How to find trusted, high-quality vitamins without overpaying
Thinking about taking supplements to jump-start your health goals? Because supplements aren’t tightly regulated before hitting the market,…
FDA Goon Delivers Wild Take on Prescription Drug Safety
FDA commissioner Marty Makary said it would be “magical” for consumers to see prescription drugs on pharmacy shelves…
NRx submits 70,000-patient ketamine data to US FDA
NRx Pharmaceuticals (Nasdaq: NRXP) will submit real-world evidence from over 70,000 patients treated with intravenous ketamine…
FDA turns down Hetlioz for jet lag once again
Vanda Pharma may have forced the FDA to revisit its marketing application for Hetlioz as a therapy for…